Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • DNA/RNA Synthesis
    (1)
  • HCV Protease
    (2)
  • HIV Protease
    (2)
  • Reverse Transcriptase
    (1)
  • Others
    (11)
Filter
Search Result
Results for "

nonnucleoside

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    17
    TargetMol | Activity
VCH-916 free acid(1200133-34-1 free base)
TQ0122L914778-92-0
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
  • $68
In Stock
Size
QTY
ABT-072
T140861132936-00-5In house
ABT-072 is a nonnucleoside NS5B polymerase inhibitor and a candidate drug evaluated for treatment of hepatitis C virus.
  • $1,780
10-14 weeks
Size
QTY
RO-0335
T9223867365-76-2
RO-0335 is a potent diphenylether nonnucleoside reverse transcriptase inhibitor. RO-0335 inhibits Wt HIV-1 (IC50 = 1.1 nM) and retained activity (IC50< 100 nM) against 92% of a large number of NNRTI-resistant clinical isolates.
  • $51
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Reverse transcriptase-IN-1
T127152380001-43-2
Reverse transcriptase-IN-1 is a diarylbenzopyrimidine (DABP) analogue and a potent inhibitor of HIV-1 nonnucleoside reverse transcriptase with an IC50of 13.7 nM.
  • $97
In Stock
Size
QTY
TargetMol | Inhibitor Sale
NSAH
T88001099592-35-4
NSAH (2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide) is a nonnucleoside inhibitor of human ribonucleotide reductase (hRR).with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively.
  • $64
In Stock
Size
QTY
TargetMol | Inhibitor Sale
U 95133
T70212177577-59-2
U 95133 is a potent, broad-spectrum nonnucleoside reverse transcriptase inhibitor of drug-resistant isolates of human immunodeficiency virus type 1.
  • $1,520
6-8 weeks
Size
QTY
A 75925
T26442129467-48-7
A 75925, a nonnucleoside reverse transcriptase inhibitors (NNRTI), works to inhibit HIV-1 replication.
  • $1,670
6-8 weeks
Size
QTY
PYR01
T781672560576-15-8
PYR01 is a potent nonnucleoside reverse transcriptase inhibitor of HIV-1 and concurrently acts as a targeted activator to eliminate cells expressing HIV-1 [1].
  • Inquiry Price
8-10 weeks
Size
QTY
Efavirenz, (R)-
T25363154801-74-8
Efavirenz, (R)- is an antiviral agent and a nonnucleoside HIV-1 reverse transcriptase inhibitor.
  • $1,520
6-8 weeks
Size
QTY
VCH-916
TQ01221200133-34-1
VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.
  • $79
5 days
Size
QTY
GSK 224876
T274421097733-15-7
GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects.
  • $1,670
6-8 weeks
Size
QTY
SJ-3366
T24794195720-26-4
SJ3366 is a unique and highly potent nonnucleoside reverse transcriptase human immunodeficiency virus type 1 and HIV-2 inhibitor.
  • $1,520
6-8 weeks
Size
QTY
MIV-150
T16081231957-54-3
MIV-150 is a nonnucleoside inhibitor of reverse transcriptase (NNRT). MIV-150 also blocking HIV-1 and HIV-2 infections (EC50<1 nM against HIV-1/HIV-2MN).
  • $275
35 days
Size
QTY
AT 61
T30185300669-68-5
AT-61 is a nonnucleoside analogue inhibitor of hepatitis B virus (HBV) replication.
  • $1,520
6-8 weeks
Size
QTY
CP-94707
T31085343250-05-5
CP-94707 is a new inhibitor of nonnucleoside reverse transcriptase (NNRTI).
  • $1,520
6-8 weeks
Size
QTY
(+)-Dihydrocalanolide A
T72283183904-53-2
(+)-Dihydrocalanolide A (DHCal A; NSC 678323), an orally active non-nucleoside reverse transcriptase inhibitor, is used in HIV infection research.
  • $1,520
6-8 weeks
Size
QTY
Emivirine
T27260149950-60-7
Emivirine (MKC-442) is a potent and selective nonnucleoside reverse transcriptase inhibitor for human immunodeficiency virus type 1.
  • $30
In Stock
Size
QTY